TWD
FLGT icon

True Wealth Design’s Fulgent Genetics FLGT Stock Holding History

True Wealth Design’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431 Buy
+21
New +$356 ﹤0.01% 2245
2025
Q3 		– Sell
-2
Closed -$40 – 2776
2025
Q2 		$40 Buy
+2
New +$39 ﹤0.01% 2423

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

True Wealth Design's FLGT Position: Q2 2026 in Review

True Wealth Design opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 21 shares worth $431. The stake represents ﹤0.01% of the portfolio and ranks #2245 among its holdings. This is a return to the name: True Wealth Design previously reported a position in FLGT as recently as Q2 2025.

True Wealth Design first reported a position in FLGT in Q2 2025 and has held it in 2 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • True Wealth Design held 21 shares of Fulgent Genetics worth $431 as of Q2 2026.
  • Fulgent Genetics was a new True Wealth Design position in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2245 holding.
  • True Wealth Design first reported a position in Fulgent Genetics in Q2 2025 and has held it in 2 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.